Stk24 protects against obesity-associated metabolic disorders by disrupting the NLRP3 inflammasome

Qiang Qin1, Jia'nan Shou1, Mengjie Li1

  • 1Institute of Immunology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China.

Cell Reports
|May 26, 2021
PubMed

Insights

Serine/threonine protein kinase 24 (Stk24) is reduced in obesity, worsening metabolic disorders. Restoring Stk24 function may treat obesity-related conditions by reducing inflammation.

Area of Science:

  • Metabolic disorders
  • Immunology
  • Obesity research

Background:

  • Adipose tissue macrophages (ATMs) play a critical role in obesity and related metabolic diseases.
  • Understanding the molecular mechanisms regulating ATM function is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of serine/threonine protein kinase 24 (Stk24) in adipose tissue macrophages (ATMs) in the context of obesity and metabolic dysfunction.
  • To elucidate the molecular mechanisms by which Stk24 influences metabolic health.

Main Methods:

  • Analysis of Stk24 expression in ATMs from human subjects and mice under conditions of obesity and high-fat diet (HFD) feeding.
  • Investigation of Stk24 function using Stk24-deficient mice and assessment of metabolic parameters and insulin sensitivity.
  • Exploration of the molecular interaction between Stk24 and NLRP3 inflammasome components in ATMs.

Main Results:

  • Stk24 expression is significantly downregulated in ATMs of obese subjects, individuals with type 2 diabetes, and mice fed an HFD.
  • Glucolipotoxicity was identified as a factor that downregulates Stk24 expression in ATMs.
  • Stk24-deficient mice exhibited exacerbated HFD-induced metabolic disorders and insulin insensitivity.
  • Stk24 directly interacts with NLRP3, inhibiting NLRP3 inflammasome assembly and subsequent interleukin-1β (IL-1β) secretion.
  • Hematopoietic Stk24 deficiency promoted NLRP3 inflammasome activation, worsening metabolic disorders.
  • Human subject data showed a negative correlation between Stk24 expression and body mass index (BMI), glucose, cholesterol, triglycerides, and low-density lipoprotein levels.

Conclusions:

  • Stk24 plays a protective role against obesity-mediated metabolic disorders by regulating ATM inflammatory responses.
  • Stk24 acts as a negative regulator of NLRP3 inflammasome activation in ATMs.
  • Stk24 represents a potential therapeutic target for managing obesity and associated metabolic complications.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.0K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K